-+ 0.00%
-+ 0.00%
-+ 0.00%

RHYTHM PHARMACEUTICALS ANNOUNCES NICE GUIDANCE FOR IMCIVREE® (SETMELANOTIDE) UPDATED TO INCLUDE ADULTS LIVING WITH BARDET-BIEDL SYNDROME

Reuters·11/04/2026 13:00:05

Please log in to view news